XML 70 R52.htm IDEA: XBRL DOCUMENT v3.22.4
Acquisitions and Divestitures (Tables)
12 Months Ended
Dec. 31, 2022
Business Combinations [Abstract]  
Schedule of Components of Routine Acquisitions
During 2022, 2021 and 2020, the Company acquired dialysis businesses and other businesses, including a transplant software company, as follows:
Year ended Year ended December 31,
202220212020
Cash paid, net of cash acquired$57,308 $187,050 $182,013 
Contingent earn-out obligations4,261 14,854 14,042 
Deferred purchase price and liabilities assumed15,076 10,226 20,415 
Non-cash gain— — 1,821 
Aggregate consideration$76,645 $212,130 $218,291 
Number of dialysis centers acquired — U.S.5198
Number of dialysis centers acquired — International111766
Aggregate Purchase Cost Allocations for Acquisitions
The following table summarizes the assets acquired and liabilities assumed in these transactions and recognized at their acquisition dates at estimated fair values, as well as the estimated fair value of noncontrolling interests assumed in these transactions:
 Year ended December 31,
 202220212020
Current assets$6,389 $9,134 $23,607 
Property and equipment7,481 9,277 37,457 
Customer relationships— 17,200 34,625 
Noncompetition agreements and other long-term assets1,066 9,964 10,168 
Indefinite-lived licenses19,610 11,432 22,136 
Goodwill49,047 173,244 130,057 
Deferred income taxes— — (3,962)
Liabilities assumed(6,081)(14,200)(34,068)
Noncontrolling interests assumed(867)(3,921)(1,729)
$76,645 $212,130 $218,291 
Schedule of other information related to acquired intangibles and goodwill
The following summarizes weighted-average estimated useful lives of amortizable intangible assets acquired during 2022, 2021 and 2020, as well as goodwill deductible for tax purposes associated with these acquisitions:
Year ended December 31,
202220212020
Weighted-average estimated useful lives (in years):
Customer relationships— 1018
Noncompetition agreements465
Goodwill deductible for tax purposes$49,047 $169,014 $94,318 
Pro Forma Summary of Results of Operations
The following summary, prepared on a pro forma basis, combines the results of operations as if all acquisitions within continuing operations in 2022 and 2021 had been consummated as of the beginning of 2021, including the impact of certain adjustments such as amortization of intangibles, interest expense on acquisition financing and income tax effects.
 Year ended December 31,
 20222021
 (unaudited)
Pro forma total revenues$11,624,270 $11,706,823 
Pro forma net income from continuing operations attributable to
 DaVita Inc.
$545,859 $984,227 
Pro forma basic net income per share from continuing operations
 attributable to DaVita Inc.
$5.87 $9.35 
Pro forma diluted net income per share from continuing operations
 attributable to DaVita Inc.
$5.70 $8.95 
Reconciliation of Changes in Contingent Earn-Out Obligations The following is a reconciliation of changes in contingent earn-out liabilities for the years ended December 31, 2022 and 2021: 
Year ended December 31,
20222021
Beginning balance$33,600 $30,248 
Acquisitions4,261 14,854 
Foreign currency translation840 (1,674)
Fair value remeasurements(5,921)(1,292)
Payments or other settlements(7,358)(8,536)
Ending balance$25,422 $33,600